Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly

被引:1
作者
Kim, Young Ju [1 ,2 ]
Yun, Jihwan [1 ,3 ]
Seo, Sang Won [1 ,2 ,4 ,5 ]
Kim, Jun Pyo [1 ,2 ]
Jang, Hyemin [1 ,6 ]
Kim, Hee Jin [1 ,2 ,4 ,5 ]
Na, Duk L. [1 ,2 ]
Woo, Sookyoung [7 ]
Chun, Min Young [1 ,8 ,9 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea
[2] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea
[3] Soonchunhyang Univ, Bucheon Hosp, Sch Med, Dept Neurol, Bucheon, South Korea
[4] Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul, South Korea
[5] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea
[6] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, Seoul, South Korea
[7] Samsung Biomed Res Inst, Biostat Team, Seoul, South Korea
[8] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea
[9] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Dept Neurol, Yongin, South Korea
关键词
Alzheimer's disease; amyloid; cognition; latent class growth analysis; longitudinal study; positron emission tomography; trajectory; PRECLINICAL ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; DECLINE; ASSOCIATION; DEPOSITION; EPSILON-4; FRAMEWORK; PATHOLOGY;
D O I
10.1111/ene.16482
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: Amyloid (3 (A(3), a major biomarker of Alzheimer's disease, leads to tau accumulation, neurodegeneration and cognitive decline. Modelling the trajectory of A(3 accumulation in cognitively unimpaired (CU) individuals is crucial, as treatments targeting A(3 are anticipated. The evolution of A(3 levels was investigated to determine whether it could lead to classification into different groups by studying longitudinal A(3 changes in older CU individuals, and differences between the groups were compared. Methods: A total of 297 CU participants were included from the Alzheimer's Disease Neuroimaging Initiative database, and these participants underwent apolipoprotein E (APOE) genotyping, neuropsychological testing, brain magnetic resonance imaging, and an average of 3.03 follow-up 18 F-florbetapir positron emission tomography scans. Distinct A(3 trajectory patterns were classified using latent class growth analysis, and longitudinal cognitive performances across these patterns were assessed with a linear mixed effects model. Results: The optimal model consisted of three classes, with a high entropy value of 0.947. The classes were designated as follows: class 1, non-accumulation group (n n = 197); class 2, late accumulation group (n n = 70); and class 3, early accumulation group (n n = 30). The late accumulation and early accumulation groups had more APOE epsilon 4 carriers than the non- accumulation group. The longitudinal analysis of cognitive performance revealed that the early accumulation group showed the steepest decline (modified Preclinical Alzheimer's Cognitive Composite with digit symbol substitution [mPACCdigit], p < 0.001; modified Preclinical Alzheimer's Cognitive Composite with trails B [mPACCtrailsB], p < 0.001) and the late accumulation group showed a steeper decline (mPACCdigit, p = 0.014; mPACCtrailsB, p = 0.007) compared to the non-accumulation group. Conclusions: Our study showed the heterogeneity of A[3 accumulation trajectories in CU older individuals. The prognoses for cognitive decline differ according to the A[3 trajectory patterns.
引用
收藏
页数:10
相关论文
共 50 条
[21]   Cerebral Amyloid Deposition and Dual-Tasking in Cognitively Normal, Mobility Unimpaired Older Adults [J].
Nadkami, Neelesh K. ;
Lopez, Oscar L. ;
Perera, Subashan ;
Studenski, Stephanie A. ;
Snitz, Beth E. ;
Erickson, Kirk I. ;
Mathis, Chester A. ;
Nebes, Robert D. ;
Redfern, Mark ;
Klunk, William E. .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2017, 72 (03) :431-437
[22]   Amyloid-β positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes [J].
Cook, Noah ;
Driscoll, Ira ;
Gaitan, Julian M. ;
Glittenberg, Matthew ;
Betthauser, Tobey J. ;
Carlsson, Cynthia M. ;
Johnson, Sterling C. ;
Asthana, Sanjay ;
Zetterberg, Henrik ;
Blennow, Kaj ;
Kollmorgen, Gwendlyn ;
Quijano-Rubio, Clara ;
Dubal, Dena B. ;
Okonkwo, Ozioma C. .
JOURNAL OF ALZHEIMERS DISEASE, 2024, 102 (02) :480-490
[23]   APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly [J].
Anniina Snellman ;
Laura L. Ekblad ;
Jouni Tuisku ;
Mikko Koivumäki ;
Nicholas J. Ashton ;
Juan Lantero-Rodriguez ;
Thomas K. Karikari ;
Semi Helin ;
Marco Bucci ;
Eliisa Löyttyniemi ;
Riitta Parkkola ;
Mira Karrasch ;
Michael Schöll ;
Henrik Zetterberg ;
Kaj Blennow ;
Juha O. Rinne .
Alzheimer's Research & Therapy, 15
[24]   The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults [J].
Bamford, Alison R. ;
Adams, Jenna N. ;
Kim, Soyun ;
McMillan, Liv C. ;
Malhas, Rond ;
Mapstone, Mark ;
Hitt, Brian D. ;
Yassa, Michael A. ;
Thomas, Elizabeth A. .
NEUROBIOLOGY OF AGING, 2024, 144 :12-18
[25]   Indicators of amyloid burden in a population-based study of cognitively normal elderly [J].
Mielke, Michelle M. ;
Wiste, Heather J. ;
Weigand, Stephen D. ;
Knopman, David S. ;
Lowe, Val J. ;
Roberts, Rosebud O. ;
Geda, Yonas E. ;
Swenson-Dravis, Dana M. ;
Boeve, Bradley F. ;
Senjem, Matthew L. ;
Vemuri, Prashanthi ;
Petersen, Ronald C. ;
Jack, Clifford R., Jr. .
NEUROLOGY, 2012, 79 (15) :1570-1577
[26]   The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly [J].
Wirth, Miranka ;
Oh, Hwamee ;
Mormino, Elizabeth C. ;
Markley, Candace ;
Landau, Susan M. ;
Jagust, William J. .
ALZHEIMERS & DEMENTIA, 2013, 9 (06) :687-698
[27]   Amyloid and Tau Pathology in Cognitively Unimpaired Individuals With a Parental History of Alzheimer Disease [J].
Ourry, Valentin ;
Fajardo-Valdez, Alfonso ;
Soucy, Jean-Paul ;
Poirier, Judes ;
Breitner, John C. S. ;
Villeneuve, Sylvia .
NEUROLOGY, 2025, 104 (09)
[28]   Respective influence of beta-amyloid and APOE ε4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults [J].
de Flores, Robin ;
Kuhn, Elizabeth ;
Landeau, Brigitte ;
Delcroix, Nicolas ;
Gonneaud, Julie ;
Vivien, Denis ;
Demeilliez-Servouin, Solene ;
Chauveau, Lea ;
Chetelat, Gael .
NEUROBIOLOGY OF DISEASE, 2023, 181
[29]   Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly [J].
Koivumaki, Mikko ;
Ekblad, Laura ;
Lantero-Rodriguez, Juan ;
Ashton, Nicholas J. ;
Karikari, Thomas K. ;
Helin, Semi ;
Parkkola, Riitta ;
Lotjonen, Jyrki ;
Zetterberg, Henrik ;
Blennow, Kaj ;
Rinne, Juha O. ;
Snellman, Anniina .
ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
[30]   Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease [J].
Chatterjee, Pratishtha ;
Elmi, Mitra ;
Goozee, Kathryn ;
Shah, Tejal ;
Sohrabi, Hamid R. ;
Dias, Cintia B. ;
Pedrini, Steve ;
Shen, Kaikai ;
Asih, Prita R. ;
Dave, Preeti ;
Taddei, Kevin ;
Vanderstichele, Hugo ;
Zetterberg, Henrik ;
Blennow, Kaj ;
Martins, Ralph N. .
JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (03) :775-783